NCT04295642View on ClinicalTrials.gov

A 2-Part Trial of CVL-751 in Subjects With Parkinson's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 8, 2020

Primary Completion Date

July 23, 2021

Study Completion Date

July 23, 2021

Conditions
Parkinson Disease
Interventions
DRUG

CVL-751

Oral tablet

Trial Locations (2)

30331

Atlanta Center for Medical Research, Atlanta

90806

CNS Network, Long Beach

Sponsors
All Listed Sponsors
lead

Cerevel Therapeutics, LLC

INDUSTRY

NCT04295642 - A 2-Part Trial of CVL-751 in Subjects With Parkinson's Disease | Biotech Hunter | Biotech Hunter